Viewing nowRosutinem Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201904801 · Approved 2019.07.18 · Insurance code 622803640
Treatment of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
This medication is used as an adjunct when dietary measures and exercise have not been sufficient in patients with primary hypercholesterolemia and mixed dyslipidemia. It is also used as an adjunct therapy in patients with homozygous familial hypercholesterolemia. It lowers total cholesterol and LDL-cholesterol in hypercholesterolemic patients, effectively delaying the progression of atherosclerosis. Additionally, it is used as an adjunct to diet in patients with primary dysbetalipoproteinemia. This medication helps reduce the risk of cardiovascular diseases, supporting a decrease in the risk of stroke, myocardial infarction, and post-arterial revascularization. Therefore, it is effectively used for the prevention of hypercholesterolemia and related cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the maintenance dose may be adjusted if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
This medication should not be used in certain patients. For example, those with allergies to any of its ingredients, severe liver impairment, muscle diseases, and women who are pregnant or breastfeeding should not take this medication. Additionally, individuals with severe kidney impairment or those taking certain immunosuppressants should be cautious. Since this medication can affect liver function, individuals with a history of heavy alcohol use or liver disease should undergo liver tests before taking it and check their liver condition regularly during treatment. It is advisable to use this medication after treating underlying conditions, such as hypothyroidism or nephrotic syndrome. Muscle pain or weakness may occur, and rarely, severe muscle damage may result, so any unusual muscle symptoms should be reported to a doctor immediately. Special caution is necessary for the elderly, individuals with reduced kidney function, those who consume excessive alcohol, and those with a family history of muscle disease. This medication contains lactose, so individuals with lactose intolerance should avoid taking it. Furthermore, this medication can interact with many other drugs, so it is essential to inform healthcare providers about any medications currently being taken. In particular, taking it with certain antiviral agents, immunosuppressants, antifungals, antibiotics, and lipid-lowering drugs may increase the risk of muscle damage. Women who are pregnant or may become pregnant should practice appropriate contraception when taking this medication due to potential risks to the fetus, and they should stop taking it immediately if pregnancy is confirmed. It is also advised that lactating women do not take this medication. In the case of an overdose, there are no specific antidotes, so treatment should be symptomatic, and liver and muscle conditions should be monitored regularly. Caution is advised while driving or operating machinery as dizziness may occur. Lastly, this medication can rarely cause severe skin reactions, liver damage, or kidney problems, so if any unusual symptoms occur, medical advice should be sought immediately.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal bloating, syncope, generalized pain, fatigue, joint pain, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air or moisture. Store the medicine at room temperature, between 1°C and 30°C, away from extreme heat or cold.
Pink round film-coated tablet
100 tablets/box [(10 tablets/PTP) X 10], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.